Technical Analysis for NEOS - Neos Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 1.85 5.11% 0.09
NEOS closed up 5.11 percent on Friday, August 16, 2019, on 65 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical NEOS trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
New Uptrend Bullish 5.11%
Wide Bands Range Expansion 5.11%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 8.82%
Wide Bands Range Expansion 8.82%
Down 3 Days in a Row Weakness 8.82%
Stochastic Sell Signal Bearish 8.19%
NR7 Range Contraction 8.19%

Older signals for NEOS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.
Pharmaceutical Drugs Pharmacology Euphoriants Psychoactive Drugs Attention Deficit Hyperactivity Disorder Cough Hydrocodone Adhd Allergies Treatment Of Attention Deficit Hyperactivity Disorder Amphetamine Drug Delivery Technologies Methylphenidate Nootropics
Is NEOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.0
52 Week Low 1.13
Average Volume 465,790
200-Day Moving Average 1.9859
50-Day Moving Average 1.4076
20-Day Moving Average 1.467
10-Day Moving Average 1.62
Average True Range 0.1445
ADX 26.27
+DI 34.2871
-DI 14.302
Chandelier Exit (Long, 3 ATRs ) 1.5165
Chandelier Exit (Short, 3 ATRs ) 1.5835
Upper Bollinger Band 1.8977
Lower Bollinger Band 1.0363
Percent B (%b) 0.94
BandWidth 58.718473
MACD Line 0.104
MACD Signal Line 0.0527
MACD Histogram 0.0513
Fundamentals Value
Market Cap 51.95 Million
Num Shares 28.1 Million
EPS -4.30
Price-to-Earnings (P/E) Ratio -0.43
Price-to-Sales 18.06
Price-to-Book 10.86
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.23
Resistance 3 (R3) 2.21 2.07 2.16
Resistance 2 (R2) 2.07 1.97 2.08 2.14
Resistance 1 (R1) 1.96 1.92 2.02 1.98 2.12
Pivot Point 1.82 1.82 1.85 1.83 1.82
Support 1 (S1) 1.71 1.72 1.77 1.73 1.58
Support 2 (S2) 1.57 1.67 1.58 1.56
Support 3 (S3) 1.46 1.57 1.54
Support 4 (S4) 1.48